Zobrazeno 1 - 3
of 3
pro vyhledávání: ''
Autor:
Jan Budczies, Jana Barinoff, Jens Huober, Wolfgang Eiermann, E. Erbstößer, Hans Tesch, Judith Prinzler, Carsten Denkert, J-U Blohmer, Jörn Hilfrich, Thomas Rüdiger, B. M. Müller, Wolfgang D. Schmitt, Keyur Mehta, Bernd Gerber, S. Loibl, Tanja Fehm, G. von Minckwitz, Holger Eidtmann, C. Jackisch
Publikováno v:
Annals of Oncology; Vol 24
BACKGROUND The proliferation marker Ki67 has been suggested as a promising cancer biomarker. As Ki67 needs an exact quantification, this marker is a prototype of a new generation of tissue-based biomarkers. In this study, we have systematically evalu
Autor:
Ivano Bertini, Patrick G. Morris, Leonardo Tenori, Edoardo Saccenti, Patrizia Bernini, A. Di Leo, Stefano Nepi, Claudio Luchinat, Elena Zafarana, Silvia Cappadona, Catherine Oakman, Laura Biganzoli, Monica Fornier, Wederson M. Claudino, A. Battaglia
Publikováno v:
Annals of Oncology; Vol 22
Background Prognostic tools in early breast cancer are inadequate. The evolving field of metabolomics may allow more accurate identification of patients with residual micrometastases. Patients and methods Forty-four early breast cancer patients with
Autor:
Meredith M. Regan, William Oh, S. Urakami, Wm. Kevin Kelly, Susan Halabi, Elizabeth O'Donnell, N. Kikuno, William R. Berry
Publikováno v:
ANNALS OF ONCOLOGY. 21(2):312-318
Background Docetaxel is associated with prolonged survival in castration-resistant prostate cancer (CRPC). Platinum compounds have modest but distinct single-agent activity. Carboplatin may have greatest potential for benefit when combined with taxan